Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Acute ST-elevation Myocardial Infarction (RITA-MI)
NCT03072199Phase 2Completed
- Start
- Jun 2017
- Primary completion
- Mar 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in myocardial infarction (MI). Started Jun 2017; status: completed.
02
Drugs
rituximab
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT03072199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03072199.